Updated:
Belgian Investment Company for Developing Countries
Belgian Investment Company for Developing Countries (BIO) is a Brussels-based investment firm founded in 2001. It invests directly in private sector projects...
Overview
Belgian Investment Company for Developing Countries (BIO) is a Brussels-based investment firm founded in 2001. It invests directly in private sector projects in developing and emerging countries, making a structural contribution to socio-economic growth. BIO has made 62 investments, including a recent investment in Orchidia Pharmaceutical Industries as part of Private Equity - II on March 11, 2026.
General information
Firm type
Government / Public Body
Year founded
2001
Location
Region
Europe
Country
Belgium
City
Brussels
Corporate office
Boulevard Bischoffsheimlaan 15, 1000 Brussels, Belgium
Sector focus
Frequently asked questions
Who owns the Belgian Investment Company for Developing Countries?
The firm is 100% owned by the Belgian State.
What asset classes does the firm target?
Growth capital in financial services, agribusiness and renewable energy.
Does the firm commit to external funds or only direct investments?
It participates in both direct holdings and limited-partner commitments to vehicles such as REG MIFA and BluePeak Private Capital Fund.
Which regions receive the majority of capital?
Sub-Saharan Africa and India account for the largest share of deployed capital.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: